CVS Health Corporation (CVS) News
Filter CVS News Items
CVS News Results
|Loading, please wait...|
CVS News Highlights
- CVS's 30 day story count now stands at 24.
- Over the past 24 days, the trend for CVS's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
- The most mentioned tickers in articles about CVS are CANO, FMC and IBM.
Latest CVS News From Around the Web
Below are the latest news stories about CVS HEALTH CORP that investors may wish to consider to help them evaluate CVS as an investment opportunity.
Drug store company Rite-Aid (NYSE: RAD) saw its shares drop 28% on Thursday. Revenue was a reported $5.9 billion, down 3% year over year, while the company said it had a net loss of $6.07 in earnings per share (EPS) compared to an EPS loss of $1.86 in the same period a year ago. While a noncash goodwill impairment charge made that loss more than normal, the company's adjusted EPS loss was $0.63 compared to $0.41 in the second quarter of 2021.
Bulk orders for COVID-19 tests are on the rise as companies brace for a winter surge.
Looking at CVS Health Corporation's ( NYSE:CVS ) insider transactions over the last year, we can see that insiders were...
CVS Health (NYSE: CVS) has mergers and acquisitions on its mind. Earlier this month, it announced plans to acquire home health company Signify Health for $8 billion, beating out other bids from Amazon and UnitedHealth Group. On a recent earnings call, management at CVS also hinted that it was looking for a deal in primary care to expand its services further.
CVS Health (CVS) closed at $98.16 in the latest trading session, marking a +0.98% move from the prior day.
CVS Health (CVS) closed the most recent trading day at $97.21, moving -0.54% from the previous trading session.
CVS Health® (NYSE: CVS) is actively preparing for Hurricane Ian's landfall in Florida this week. The company's priority is the health and safety of its colleagues, customers, and members, and it is committed to providing its communities access to the products and services they need to plan for the storm.
There wouldn't be many who think CVS Health Corporation's ( NYSE:CVS ) price-to-earnings (or "P/E") ratio of 15.8x is...
Cano Health (CANO) stock is moving on Friday from reports that Humana (HUM) and CVS (CVS) are considering buying the company.
A manufacturing-quality problem has led to some vaccine providers only offering the Pfizer-BioNTech booster shot.